| Quarterly Financials | Mar 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 216 | 278 | 260 | 293 | 331 | 402 | 300 | 296 | 300 | 303 | 334 | 328 | 342 | 282 | 314 | 293 | 326 | 384 | 318 | 338 | 319 | 407 | 432 | 421 | 545 | 438 | 450 | 516 | 547 |
| Expenses | 192 | 260 | 276 | 318 | 325 | 350 | 294 | 295 | 292 | 277 | 305 | 288 | 296 | 255 | 300 | 284 | 313 | 302 | 311 | 352 | 345 | 419 | 395 | 407 | 435 | 532 | 403 | 452 | 448 |
| EBITDA | 24 | 18 | -16 | -25 | 5 | 52 | 6 | 1 | 8 | 26 | 29 | 40 | 46 | 27 | 14 | 9 | 13 | 83 | 7 | -14 | -26 | -12 | 37 | 14 | 110 | -94 | 47 | 64 | 99 |
| Operating Profit % | -3 % | -10 % | -14 % | -22 % | -7 % | 7 % | -7 % | -10 % | -6 % | 5 % | 4 % | 9 % | 9 % | 7 % | -1 % | 2 % | -0 % | 19 % | -0 % | -7 % | -14 % | -4 % | 7 % | 2 % | 7 % | -23 % | 10 % | 11 % | 16 % |
| Depreciation | 11 | 14 | 14 | 16 | 18 | 19 | 18 | 21 | 20 | 23 | 21 | 21 | 21 | 22 | 22 | 22 | 23 | 23 | 25 | 28 | 31 | 30 | 29 | 30 | 32 | 27 | 28 | 32 | 31 |
| Interest | 0 | 3 | 1 | 1 | 1 | 4 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 2 | 3 | 5 | 4 | 6 | 6 | 7 | 6 | 5 | 4 | 5 | 7 |
| Profit Before Tax | 13 | 2 | -31 | -43 | -14 | 29 | -14 | -22 | -13 | 0 | 7 | 18 | 24 | 3 | -9 | -16 | -11 | 58 | -21 | -47 | -61 | -47 | 2 | -22 | 73 | -126 | 15 | 27 | 62 |
| Tax | -16 | 4 | -10 | -2 | -14 | -9 | -8 | 1 | 1 | 18 | 5 | 9 | -0 | 3 | 2 | -3 | 3 | -14 | 3 | 23 | 3 | -3 | 3 | 3 | 0 | 3 | 6 | 3 | 4 |
| Net Profit | 29 | -2 | -21 | -41 | -0 | 38 | -6 | -22 | -15 | -17 | 2 | 9 | 24 | -0 | -12 | -13 | -14 | 72 | -23 | -71 | -64 | -44 | -1 | -25 | 73 | -129 | 9 | 25 | 58 |
| EPS in ₹ | 3.19 | 0.00 | -2.91 | -5.83 | -0.04 | 4.51 | -0.88 | -3.15 | -2.07 | -2.44 | 0.35 | 1.24 | 3.35 | -0.06 | -1.63 | -1.82 | -2.01 | 10.15 | -3.32 | -10.04 | -9.08 | -6.28 | -0.09 | -3.48 | 10.39 | -18.37 | 1.31 | 3.50 | 8.22 |
Unichem Laboratories
638.80
-21.35
(-3.23%)
Market Cap
4,497.52 Cr
EPS
-10.01
PE Ratio
54.83
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
937.95
52 Week low
472.75
PB Ratio
1.93
Debt to Equity
0.12
Sector
Pharmaceuticals
Live Chart 
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
| 1,683.45 | 4,03,916.05 | 34.10 | 49,887.20 | 12.06 | 9,648 | 13.77 | 52.67 | |
| 5,620.45 | 1,49,205.29 | 72.77 | 8,184.00 | 0.89 | 1,600 | 64.53 | 45.57 | |
| 1,461.90 | 1,18,065.10 | 23.53 | 26,520.70 | 14.17 | 4,155 | 47.38 | 52.92 | |
| 3,056.05 | 1,03,430.62 | 56.27 | 10,785.70 | 11.59 | 1,656 | 13.54 | 47.23 | |
| 1,107.95 | 92,448.55 | 17.17 | 28,905.40 | 12.36 | 5,578 | 1.69 | 30.37 | |
| 2,201.15 | 90,812.16 | 43.84 | 10,615.60 | 19.57 | 1,942 | -16.38 | 35.15 | |
| 1,968.45 | 89,800.21 | 31.28 | 20,141.50 | 19.94 | 1,936 | 38.82 | 43.62 | |
| 883.10 | 88,860.52 | 19.73 | 19,831.50 | 13.82 | 3,831 | 29.92 | 40.81 | |
| 1,094.75 | 63,583.26 | 18.24 | 29,559.20 | 17.55 | 3,169 | -10.04 | 43.94 | |
| 29,597.00 | 62,891.56 | 47.49 | 6,097.20 | 10.80 | 1,201 | 16.01 | 49.75 |
Growth Rate
Revenue Growth
25.70 %
Net Income Growth
-65.13 %
Cash Flow Change
119.61 %
ROE
-64.10 %
ROCE
-74.64 %
EBITDA Margin (Avg.)
-1,588.24 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 1,169 | 1,284 | 1,527 | 3,194 | 3,150 | 3,145 | 3,126 | 3,319 | 3,193 | 3,169 |
| Fixed Assets | 416 | 403 | 491 | 578 | 810 | 870 | 884 | 990 | 1,257 | 1,196 |
| Current Assets | 564 | 600 | 749 | 2,337 | 2,038 | 1,687 | 1,377 | 1,648 | 1,589 | 1,694 |
| Capital Work in Progress | 123 | 237 | 250 | 238 | 92 | 331 | 568 | 494 | 148 | 123 |
| Investments | 35 | 14 | 14 | 901 | 926 | 550 | 392 | 264 | 2 | 1 |
| Other Assets | 595 | 630 | 772 | 1,476 | 1,321 | 1,395 | 1,282 | 1,571 | 1,787 | 1,849 |
| Total Liabilities | 1,169 | 1,284 | 1,527 | 3,194 | 3,150 | 3,145 | 3,126 | 3,319 | 3,193 | 3,169 |
| Current Liabilities | 212 | 243 | 393 | 464 | 503 | 567 | 506 | 552 | 640 | 708 |
| Non Current Liabilities | 89 | 86 | 70 | 50 | 27 | 47 | 63 | 148 | 118 | 99 |
| Total Equity | 868 | 954 | 1,064 | 2,680 | 2,620 | 2,531 | 2,557 | 2,618 | 2,435 | 2,362 |
| Reserve & Surplus | 849 | 936 | 1,045 | 2,666 | 2,606 | 2,517 | 2,543 | 2,604 | 2,421 | 2,348 |
| Share Capital | 18 | 18 | 18 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | -25 | -7 | -1 | 655 | -616 | -78 | -154 | 32 | 75 | -33 |
| Investing Activities | -52 | -85 | -128 | 1,648 | -286 | -36 | -66 | 100 | 241 | 57 |
| Operating Activities | 78 | 112 | 68 | -112 | -328 | 20 | 33 | -260 | -85 | 17 |
| Financing Activities | -51 | -33 | 59 | -881 | -2 | -62 | -121 | 191 | -81 | -106 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
| Promoter | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 50.93 % | 70.21 % | 70.22 % | 70.22 % | 70.22 % | 70.22 % | 70.22 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.83 % | 0.00 % | 0.90 % | 0.89 % | 0.94 % | 1.06 % |
| DIIs | 8.49 % | 8.49 % | 8.49 % | 8.49 % | 8.49 % | 8.38 % | 7.55 % | 8.20 % | 8.16 % | 7.39 % | 10.32 % | 9.29 % | 11.27 % | 11.58 % | 11.67 % | 11.63 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 30.48 % | 30.39 % | 30.50 % | 30.27 % | 29.81 % | 29.95 % | 30.17 % | 30.99 % | 30.91 % | 26.86 % | 15.80 % | 15.63 % | 15.12 % | 14.80 % | 14.58 % | 14.47 % |
| Others | 10.09 % | 10.19 % | 10.08 % | 10.31 % | 10.77 % | 10.73 % | 11.34 % | 9.87 % | 9.99 % | 14.81 % | 2.84 % | 4.85 % | 2.49 % | 2.50 % | 2.60 % | 2.62 % |
| No of Share Holders | 0 | 33,734 | 34,258 | 33,892 | 35,313 | 33,557 | 32,666 | 29,573 | 29,418 | 26,642 | 21,584 | 20,877 | 21,171 | 20,621 | 20,374 | 21,472 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 3 | 5 | 4 | 4 | 4 | 4 | 4 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 1.05 | 2.57 | 2.57 | 1.29 | 1.54 | 1.39 | 0.81 | 0.00 | 0.00 |
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
USFDA Approval For CompanyS Pithampur API Facility
Board Meeting Outcome for Outcome Of Board Meeting
Announcement under Regulation 30 (LODR)-Credit Rating
Announcement under Regulation 30 (LODR)-Newspaper Publication
Integrated Filing (Financial)
Financial Results
Included Mr. Utkarsh Patil Chief Manufacturing Officer - Formulations As A Senior Management Personnel Under SEBI LODR Regulations With Effect From 6Th February 2025
Board Meeting Outcome for Unaudited Financial Results (Consolidated & Standalone) For The Quarter And Nine-Months Ended 31St December 2024
Announcement Under Regulation 30(LODR) - GST (Goods
&Services Tax)
Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.
Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2024.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Intimation By Registrar & Transfer Agent (RTA)
Resignation Of Senior Managerial Personnel.
Announcement under Regulation 30 (LODR)-Newspaper Publication
Amendment In Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Board Meeting Outcome for Unaudited Financial Statements (Consolidated & Standalone) For The Second Quarter And Half Year Ended 30Th September 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended September 30, 2024.
Reply Letter On A Significant Increase In The Volume.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Board Meeting Outcome for Outcome Of Board Meeting
Closure of Trading Window
Board Meeting Intimation for Integration And Consolidation Of The Generics FormulationsBusiness In The US Market.
Intimation Under Regulation 30 Of SEBI LODR
Announcement under Regulation 30 (LODR)-Newspaper Publication
Announcement under Regulation 30 (LODR)-Change in Registered Office Address
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Announcement under Regulation 30 (LODR)-Newspaper Publication
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Shareholder Meeting / Postal Ballot-Outcome of AGM
Change In Key Managerial Personnel For Determining And Disclosure Of Material Events
Board Meeting Outcome for Outcome Of Board Meeting
Outcome Of Board Meeting
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Board Meeting Intimation for Financial Results
USFDA Inspection At Goa Formulation Facility
Announcement under Regulation 30 (LODR)-Newspaper Publication
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Notice Of The 61St Annual General Meeting
Business Responsibility and Sustainability Reporting (BRSR)
Reg. 34 (1) Annual Report.
Announcement under Regulation 30 (LODR)-Newspaper Publication
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Shareholder Meeting - AGM On August 8, 2024
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Closure of Trading Window
Technical Indicators
RSI(14)
Neutral 41.02
ATR(14)
Less Volatile 36.84
STOCH(9,6)
Neutral 61.14
STOCH RSI(14)
Neutral 73.28
MACD(12,26)
Bullish 1.50
ADX(14)
Weak Trend 16.26
UO(9)
Bearish 40.46
ROC(12)
Downtrend And Accelerating -7.17
WillR(14)
Neutral -64.33
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
